109
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease

, , , , , & show all
Pages 1960-1963 | Received 20 Jan 2006, Accepted 04 Mar 2006, Published online: 01 Jul 2009

References

  • Bataller L, Dalmau J. Paraneoplastic neurologic syndromes. Neurol Clin 2003; 21: 221–247
  • Tappin J A, Satchi G. Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease. Clin Lab Haem 1995; 17: 206
  • Dropcho E J. Uptade on paraneoplastic syndromes. Curr Opinion Neurol 2005; 18: 331–336
  • Peltola G, Hietaharju A, Rantala I, Lethinen T, Haapasalo H. A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease. Acta Neurol Scand 1998; 98: 360–363
  • Chereli C, Payzin B, Undar B, Yilmaz U, Alakavuklar M N. Paraneoplastic cerebellar degeneration in association with Hodgkin's disease: a report of two cases. Acta Haematol 1995; 94: 210–213
  • Trotter J L, Hendin B A, Osterland K. Cerebellar degeneration with Hodgkin's disease. Arch Neurol 1976; 33: 600–661
  • Graus F, Dalmau J, Valldeoriola F, Ferrer I, Renè R, Marin C, et al. Immunological characterization of a neural antibody (anti.Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997; 74: 55–61
  • Bernal F, Shams S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J. Anti-Tr antibodies as a marker of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003; 60: 230–234
  • Cavalli F. Rare syndromes in Hodgkin's disease. Ann Oncol 1998; 9: S109–S113
  • Counsell C E, McLeod M, Grant R. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology 1994; 44: 1144–1145
  • Candler P M, Hart P E, Barnett M, Weil R, Res J H. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry 2004; 75: 1411–1415

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.